# A Case of Severe Neonatal Neutropenia Secondary to Late-Onset Sepsis From E. coli Omphalitis

**Authors:** Hadi Fakih, Hussein Hussein, Fatima Fakih

PMC · DOI: 10.7759/cureus.101601 · 2026-01-15

## TL;DR

A newborn with severe neutropenia was diagnosed with sepsis from E. coli omphalitis and recovered after treatment.

## Contribution

This case highlights the use of WES in diagnosing acquired neonatal neutropenia and guiding treatment.

## Key findings

- Severe neutropenia in an infant was linked to E. coli omphalitis and late-onset sepsis.
- Whole exome sequencing ruled out congenital causes, supporting an acquired diagnosis.
- The infant fully recovered with targeted antibiotic and G-CSF therapy.

## Abstract

Severe neonatal neutropenia, defined as an absolute neutrophil count (ANC) of <500/µL, is a critical hematologic finding that signals either a severe consumptive process or a primary bone marrow disorder. We present the case of an eight-day-old, full-term female infant who presented with fever and irritability, later diagnosed with severe neutropenia (ANC: 400/µL) and elevated C-reactive protein (CRP) (150 mg/L). Omphalitis was identified as the source, with pus culture growing pan-sensitive Escherichia coli, confirming late-onset neonatal sepsis (LONS). The patient was managed with targeted intravenous ceftazidime and a short course of granulocyte colony-stimulating factor (G-CSF). A comprehensive workup, including a bone marrow aspirate and whole exome sequencing (WES), was performed to rule out congenital etiologies; WES returned negative, supporting the diagnosis of acquired, sepsis-induced neutropenia. On follow-up at two months of age, the infant was asymptomatic and thriving well and had a normal complete blood count with differential (CBCD). This case underscores the importance of a systematic diagnostic approach to neonatal neutropenia, highlighting the differential diagnosis and the evolving role of advanced genetic testing such as WES in providing definitive diagnostic and prognostic clarity, thereby guiding appropriate management.

## Linked entities

- **Chemicals:** ceftazidime (PubChem CID 5481173)
- **Diseases:** omphalitis (MONDO:0021562)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** C-reactive protein [NCBI Gene 20468888]
- **Diseases:** Neonatal Neutropenia (MESH:D009503), LONS (MESH:D000071074), Sepsis (MESH:D018805), irritability (MESH:D001523), fever (MESH:D005334), bone marrow disorder (MESH:D001855)
- **Chemicals:** ceftazidime (MESH:D002442)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12906278/full.md

---
Source: https://tomesphere.com/paper/PMC12906278